Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132943) titled 'A survey of patients with head and neck squamous cell carcinoma in China' on Sept. 20.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Beijing Cancer Hospital
Condition:
Head and neck squamous cell carcinoma
Intervention:
Locally advanced head and neck squamous cell carcinoma:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-23
Target Sample Size: Locally advanced head and neck squamous cell carcinoma:230;Recurrent/metastatic head and neck squamous cell carcinoma:154;
Countries of Recruitment:
China
To know more, visit https://www...